Rash News and Research

RSS

Summertime is tick time and Lyme disease is on the rise

The Centers for Disease Control and Prevention (CDC) in the United States says cases of the tick borne illness Lyme disease are on the rise across the country.

18 Jun 2007

Lyme disease on the increase in U.S.

Reported cases of Lyme disease have more than doubled since 1991, when Lyme became a nationally notifiable disease, according to a report by the Centers for Disease Control and Prevention (CDC).

17 Jun 2007

Talcum powder stunts cancer growth

Talcum powder has been used for generations to soothe babies diaper rash and freshen women's faces.

8 Jun 2007

Endocannabinoids appear to play important role in regulating inflammation

Endocannabinoids seem to play an important role in regulating inflammation processes. Scientists from the University of Bonn have discovered this in experiments on mice.

8 Jun 2007

Axitinib shows promise in treatment of advanced thyroid cancer

The investigational drug axitinib produced tumor regression or stable disease in almost three-out-of-four patients with advanced thyroid cancer, a research team reported at the annual meeting of the American Society for Clinical Oncology in Chicago.

5 Jun 2007

Results of phase II studies of pazopanib

GlaxoSmithKline (GSK) has announced results from ongoing Phase II studies of pazopanib in advanced or metastatic renal cell carcinoma (RCC) and ovarian cancer.

5 Jun 2007

FDA approves Torisel (temsirolimus) for advanced kidney cancer

The U.S. Food and Drug Administration (FDA) hasapproved Torisel (temsirolimus) for the treatment of a certain type of advanced kidney cancer known as renal cell carcinoma.

1 Jun 2007

Temsirolimus, effective new treatment for advanced renal cell carcinoma

The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show temsirolimus improved overall survival when compared to the current treatment for this stage of disease.

1 Jun 2007

Guidelines on skin reactions to Epidermal Growth Factor Receptor Inhibitors (EGFRIs)

Skin reactions to a powerful new class of anti-cancer drugs are frequent, but manageable through a simple and rational treatment approach , usually without the need to reduce the dose or interrupt treatment with potentially life-prolonging chemotherapy, according to an article in the May issue of "The Oncologist."

24 May 2007

New treatment for toxic shock syndrome

Researchers at the University of Minnesota and the University of Illinois at Urbana-Champaign have developed a new therapeutic that neutralizes Toxic Shock Syndrome (TSS) more effectively than other treatments.

23 May 2007

FDA committee votes in favor of Acambis' smallpox vaccine

Acambis plc announced that the Vaccines and Related Biological Products Advisory Committee of the US Food and Drug Administration (FDA) voted unanimously that Acambis' smallpox vaccine, ACAM2000, is both safe and efficacious.

18 May 2007

West Nile virus case in court in Canada

Just as the first mosquitoes are appearing in parts of the United States carrying the West Nile virus, a court in Canada has ruled that an insurance company must pay a man compensation after he was bitten by a mosquito at work and developed the West Nile virus.

15 May 2007

Medicis Pharmaceutical to resolve false claims allegations

Medicis Pharmaceutical Corporation of Scottsdale, Ariz., will pay the United States $9.8 million to settle allegations that the company violated the False Claims Act with respect to claims submitted to Medicaid, the Justice Department announced.

9 May 2007

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott has announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA (adalimumab) as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. and juvenile idiopathic arthritis (JIA) in the European Union (EU).

9 May 2007

Gulf War veterans with health symptoms show differences in brain structures

Veterans of the first Gulf War who returned with multiple health symptom complaints show significant differences in brain structures from their fellow returnees without high numbers of health symptoms, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 ,May 5, 2007.

2 May 2007